MedTech Europe (MTE)

<
>
How to read and use this data card.
LOADING...
1717450
4910354980f94edb9b7b5ba88f203fba

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

800,000€ - 899,999€

Financial year: 01/01/2017 - 01/12/2017

Lobbyists declared: 2.5 FTE (10)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.

1
1

Lobbyists with EP accreditation: 5

5

Meetings with European Commission: 22

Lobbying costs over the years:

1
5
10
100
1000

MedTech Europe (MTE)

Registration on EU Transparency Register

433743725252-26 (First registered: 26 Dec 2016)

Goals / Remit

As a pan-European trade and product association representing the medical technology manufacturers that produce diagnostics, medical devices and digital health solutions in Europe, MedTech Europe's mission is to make modern, innovative and safe medical technology available to more people.
MedTech Europe aims to:
• promote the value and contribution of the medical technology industry, including diagnostics, medical devices and digital health
• raise awareness about the role that innovative medical technologies play in providing solutions to Europe’s ever-growing healthcare needs;
• anticipate and respond to new business trends;
• develop scientific expertise on questions of economic, medical and technical nature related to the medical technology industry;
• collect, develop and communicate reliable data on a wide variety of issues to its members;
• provide services, support and information that add value to our members
•encourage the contribution of the medical technology sector in the EU Research Framework Programme.


MedTech Europe has taken over on January 1st, 2017, the activities previously performed by EDMA and Eucomed.

Issues

A) Healthcare policies which affect the use and availability of IVDs and Medical Devices B) Files under the responsibility of the DG SANTE, DG GROW, DG RESEARCH, DG ENVI, DG CONNECT, DG JUST with particular focus on health, medical devices and IVDs, Innovation • Implementation of Regulation (EU) 746/2017 on in vitro diagnostic medical devices and Regulation (EU) 745/2017 on medical devices • The General Data Protection Regulation (EU) 2016/679 • Implementation of the late payments directive • Policies, Initiatives related to Antimicrobial Resistance (AMR) and Healthcare Associated Infections (HAIs) • Health Technology Assessment • Health system performance assessments / EU semester • Environmental regulations and their implementation (e.g., The WEEE and RoHS Directives, and the REACH and Biocidal Products Regulations) • Green Deal • General Product Safety directive • Patient safety and quality of care • EU Directive on Procurement • Public Procurement of Innovation Solutions • Research Framework Program • E-privacy, Digital Single Market initiatives • Digital transformation of health and care • Regulation (EU) 2019/881 on ENISA and on information and communications technology cybersecurity certification” • The European Health Data Space • Future legislation on artificial intelligence • Collective Redress • Product Liability C) Add files under the responsibility of DG TRADE, DG TAXUD and DG NEAR • Brexit • Bilateral and multilateral trade agreements • Customs procedures and tariffs • Resolution of technical barriers to trade

Address

Head office:
40 rue Joseph II
Brussels 1000,
Belgium

Tel: 32 7722212